Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 9926-9927 [2013-03130]
Download as PDF
<![CDATA[
9926
Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices
tuberculosis-related issues. Agenda
items are subject to change as priorities
dictate.
Contact Person for More Information:
Margie Scott-Cseh, CDC, 1600 Clifton
Road, NE., M/S E–07, Atlanta, Georgia
30333, telephone (404) 639–8317;
Email: zkr7@cdc.gov
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2013–03133 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
tkelley on DSK3SPTVN1PROD with NOTICES
The meeting announced below
concerns Medicaid Expansion and
Reproductive Health Care for Women,
FOA DP 13–002, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–5:00 p.m., April
4, 2013 (Closed).
Place: Teleconference .
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Medicaid Expansion and
Reproductive Health Care for Women, FOA
DP 13–002, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
VerDate Mar<15>2010
16:40 Feb 11, 2013
Jkt 229001
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2013–03131 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Prevalence and Incidence of
Inflammatory Bowel Disease, FOA DP
13–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date:
11:00 a.m.–5:00 p.m., April 16, 2013
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Prevalence and Incidence of
Inflammatory Bowel Disease, FOA DP 13–
001, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–03132 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Cooperative Research
Agreements Related to the World Trade
Center Health Program (U01) PAR 12–
126, initial review.
Correction: The notice was published
in the Federal Register on January 30,
2013, Volume 78, Number 20, Page
6329. The place should read as follows:
Place: Atlanta Marriott Century
Center, 2000 Century Boulevard NE.,
Atlanta, Georgia 30345–3306,
Telephone: (404) 325–0000.
Contact Person for More Information:
Nina Turner, Ph.D., Scientific Review
Officer, CDC, 1095 Willowdale Road,
Mailstop G800, Morgantown, West
Virginia 26505, Telephone: (304) 285–
5976.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–03134 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Cost-Benefit of Incentive-based
Smoking Cessation for Pregnant
Women, FOA DP 13–003, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–5:00 p.m., April
2, 2013 (Closed).
Place: Teleconference .
Status: The meeting will be closed to the
public in accordance with provisions set
E:\FR\FM\12FEN1.SGM
12FEN1
Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Cost-Benefit of Incentive-based
Smoking Cessation for Pregnant Women,
FOA DP 13–003, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–03130 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–685 and CMS–
R–290]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a previously
approved collection; Title of
tkelley on DSK3SPTVN1PROD with NOTICES
AGENCY:
VerDate Mar<15>2010
16:40 Feb 11, 2013
Jkt 229001
Information Collection: End Stage Renal
Disease (ESRD) Network Semi-Annual
Cost Report Forms and Supporting
Regulations in 42 CFR section 405.2110
and 42 CFR 405.2112; Use: Section
1881(c) of the Social Security Act
establishes End Stage Renal Disease
(ESRD) Network contracts. The
regulations found at 42 CFR 405.2110
and 405.2112 designated 18 ESRD
Networks which are funded by
renewable contracts. These contracts are
on 3-year cycles. To better administer
the program, CMS is requiring
contractors to submit semi-annual cost
reports. The purpose of the cost reports
is to enable the ESRD Networks to
report costs in a standardized manner.
This will allow CMS to review, compare
and project ESRD Network costs during
the life of the contract. Since the last
collection, the survey instrument has
been revised. The burden has not
changed. Form Number: CMS–685
(OMB#: 0938–0657); Frequency:
Reporting—Semi-annually; Affected
Public: Not-for-profit institutions;
Number of Respondents: 18; Total
Annual Responses: 36; Total Annual
Hours: 108. (For policy questions
regarding this collection contact
Benjamin Bernstein at 410–786–6570.
For all other issues call 410–786–1326.)
2. Type of Information Collection
Request: Reinstatement of a currently
approved collection; Title: Medicare
Program: Procedures for Making
National Coverage Decisions; Use: The
Centers for Medicare & Medicaid
Services (CMS) revised the April 27,
1999 (64 FR 22619) notice and
published a new notice on September
26, 2003 (68 FR 55634) that described
the process we use to make Medicare
coverage decisions including decisions
regarding whether new technology and
services can be covered. We have made
changes to our internal procedures in
response to the comments we received
following publication of the 1999 notice
and experience under our new process.
Over the past several years, we received
numerous suggestions to further revise
our process to continue to make it more
open, responsive, and understandable to
the public. We share the goal of
increasing public participation in the
development of Medicare coverage
issues. This will assist us in obtaining
the information we require to make a
national coverage determination in a
timely manner and ensuring that the
Medicare program continues to meet the
needs of its beneficiaries. Form Number:
CMS–R–290 (OCN: 0938–0776);
Frequency: Annual; Affected Public:
Private Sector: Business or other forprofits; Number of Respondents: 200;
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
9927
Total Annual Responses: 200; Total
Annual Hours: 8,000. (For policy
questions regarding this collection
contact Katherine Tillman at 410–786–
9252. For all other issues call 410–786–
1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by April 15, 2013:
1. Electronically. You may submit
your comments electronically to
https://www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By Regular Mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number __, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: February 6, 2013.
Martique Jones,
Deputy Director, Regulations Development
Group, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2013–03059 Filed 2–11–13; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities; Proposed Collection;
Comment Request; State Program
Report
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) is announcing
an opportunity for public comment on
the proposed collection of certain
information by the agency. Under the
SUMMARY:
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 78, Number 29 (Tuesday, February 12, 2013)]
[Notices]
[Pages 9926-9927]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03130]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Cost-Benefit of Incentive-
based Smoking Cessation for Pregnant Women, FOA DP 13-003, initial
review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11:00 a.m.-5:00 p.m., April 2, 2013 (Closed).
Place: Teleconference .
Status: The meeting will be closed to the public in accordance
with provisions set
[[Page 9927]]
forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the
Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Cost-Benefit of Incentive-based Smoking Cessation for
Pregnant Women, FOA DP 13-003, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop
F-46, Atlanta, Georgia 30341, Telephone: (770) 488-3585,
EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-03130 Filed 2-11-13; 8:45 am]
BILLING CODE 4163-18-P
